Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Stroke. 2019 Oct 18;50(11):3045–3050. doi: 10.1161/STROKEAHA.119.025376

Table 1.

Clinical Characteristics at Time of Atrial Fibrillation Diagnosis, Atherosclerosis Risk in Communities (ARIC) Study

All No MetS MetS
Characteristic N=1172 N=340 N=832 P-value
Age (Years) 71 +/− 9 68.6 +/− 8 71.6 +/−9 <0.0001
Female sex 514 (44) 143 (42) 371 (45) 0.43
Previous MI 254 (22) 49 (14) 205 (25) <0.0001
Heart failure 374 (32) 87 (26) 287 (35) 0.003
PAD 125 (11) 32 (9) 93 (11) 0.37
Past stroke/TIA 163 (14) 35 (10) 133 (16) 0.02
CHA2DS2VASc 3.4 +/− 1.8 2.5 +/− 1.6 3.7 +/− 1.7 <0.0001
Black race 194 (17) 48 (14) 146 (18) 0.15
Metabolic syndrome variables
High waist circumference 780 (67) 121 (36) 659 (79) <0.0001
High triglycerides 624 (53) 26 (8) 598 (72) <0.0001
Low HDL 704 (60) 52 (15) 652 (78) <0.0001
Elevated fasting plasma glucose 795 (68) 113 (33) 682 (82) <0.0001
Diabetes 351 (30) 23 (7) 338 (39) <0.0001
Elevated blood pressure 955 (81) 190 (56) 765 (92) <0.0001
Hypertension 819 (70) 156 (46) 663 (80) <0.0001
*

Data are presented as n (%) or mean +/− standard deviation

§

Abbreviations: Myocardial Infarction (MI), Peripheral Arterial Disease (PAD), Transient

Ischemic Attack (TIA), High-density lipoprotein (HDL).

Elevated blood glucose - Fasting plasma glucose (FPG) ≥100 mg/dL (5.6 mmol/L) or drug treatment for elevated blood glucose and includes participants with diabetes

Elevated blood pressure - Blood pressure ≥130/85 mmHg or drug treatment for elevated blood pressure and includes participants with hypertension